JT Stratford LLC’s CVS Health CVS Stock Holding History

JT Stratford LLC’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-400	Closed	-$1K	–	208
2021 Q1	$1K	Hold	400	–	–	﹤0.01%	200
2020 Q4	$1K	Buy	+400	New	+$26K	﹤0.01%	185

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JT Stratford LLC's CVS Position: Q2 2024 in Review

JT Stratford LLC sold out of CVS Health (CVS) in Q2 2024, closing a stake of 4,392 shares — an estimated $350K sold.

JT Stratford LLC first reported a position in CVS in Q2 2019 and held it in 20 quarters. The position peaked at $3.05M in Q4 2023. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

JT Stratford LLC reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
JT Stratford LLC sold 4,392 CVS Health shares in Q2 2024, an estimated $350K.
JT Stratford LLC first reported a position in CVS Health in Q2 2019 and held it in 20 quarters.
JT Stratford LLC's CVS Health position peaked at $3.05M in Q4 2023.
1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on JT Stratford LLC's 13F filing for Q2 2024, filed 14 Aug 2024.